[1]Matsuzawa Y, Funahashi T, Kihara S, et al.Adiponectin and metabol-ic syndrome[J].Arterioscler Thromb Vasc Biol, 2004, 24 (1) :29-33.
|
[2]Tschritter O, Fritsche A, Thamer C, et al.Plasma adiponectin concen-trations predict insulin sensitivity of both glucose and lipid metabo-lism[J].Diabetes, 2003, 52 (2) :239-243.
|
[3]中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) :324-329.
|
[4]Tacke F, Wustefeld T, Horn R, et al.High adiponectin in chronic liv-er disease and cholestasis suggests biliary route of adiponectin excre-tion in vivo[J].J Hepatol, 2005, 42 (5) :666-673.
|
[5]Hui CK, Zhang HY, Lee NP, et al.Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B[J].J Hepatol, 2007, 47 (2) :191-202.
|
[6]Berner HS, Lyngstadaas SP, Spahr A, et al.Adiponectin and its recep-tors are expressed in bone-forming cells[J].Bone, 2004, 35 (4) :842-849.
|
[7]Yoda-Murakami M, Taniguchi M, Takahashi K, et a1.Change in expression of GBP28/adiponectin in carbon tetrachloride-adminis-trated mouse liver[J].Biochem Biophys Res Commun, 2001, 285 (2) :372-377.
|
[8]Kaser S, Moschen A, Kaser A, et a1.Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis[J].J Intern Med, 2005, 258 (3) :274-280.
|